Seeking Alpha·United States·Wednesday, September 16, 2026 at 12:00 PM Cardiol Therapeutics raises over US$7M through warrant exercises
Translate
Khushi Singh
- Cardiol Therapeutics (CRDL) received more than US$7M from the exercise of outstanding common share purchase warrants.
- The new capital is expected to extend Cardiol’s cash runway into H1 2028 and fund operations through topline results from its pivotal Phase III
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.